<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>e-sygoing.link — Delivery Systems</title>
  <link>https://e-sygoing.link</link>
  <description>Latest links in the Delivery Systems category</description>
  <language>en-us</language>
  <lastBuildDate>Tue, 09 Jun 2026 23:08:06 -0400</lastBuildDate>
  <atom:link href="https://e-sygoing.link/rss.php?type=new&amp;cid=87290"
             rel="self" type="application/rss+xml"/>
    <item>
    <title>IC-VEC Ltd.</title>
    <link>https://e-sygoing.link/link/5624377-ic-vec-ltd</link>
    <description>Non-viral drug delivery technology based on cationic liposomes, under clinical development for vector systems on license from Imperial College, London, UK.</description>
    <pubDate>Thu, 03 Apr 2025 13:25:39 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624377</guid>
  </item>
    <item>
    <title>TheraCyte, Inc.</title>
    <link>https://e-sygoing.link/link/5624382-theracyte-inc</link>
    <description>Offers products for regulated insulin and alpha-interferon, and develops engineered human cells for implanting genes. Includes technology overview and profile of company in Irvine, California.</description>
    <pubDate>Mon, 06 Jan 2025 03:32:12 -0500</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624382</guid>
  </item>
    <item>
    <title>Advanced Biomedical</title>
    <link>https://e-sygoing.link/link/5624378-advanced-biomedical</link>
    <description>Manufactures custom peptides, protein conjugates and liposomes.  Includes technology overview, applications, request forms and contacts in North West England.</description>
    <pubDate>Sat, 10 Aug 2024 06:45:09 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624378</guid>
  </item>
    <item>
    <title>BioRexis Pharmaceutical Corp.</title>
    <link>https://e-sygoing.link/link/5624379-biorexis-pharmaceutical-corp</link>
    <description>Company with proprietary technology to enhance half-life and therapeutic efficacy, by fusing bioactive protein sequence to human transferrin, and using yeast host cell expression systems for production. Opportunities and contacts in King of Prussia, Pennsylvania.</description>
    <pubDate>Fri, 05 Apr 2024 22:27:35 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624379</guid>
  </item>
    <item>
    <title>ConjuChem, Inc.</title>
    <link>https://e-sygoing.link/link/5624380-conjuchem-inc</link>
    <description>Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview,  research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada.</description>
    <pubDate>Fri, 19 May 2023 04:48:40 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624380</guid>
  </item>
  </channel>
</rss>
